Charming Medical Limited
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| – | -87.9% | +44.2% | -385.5% | |
| – | +85.6% | -32.7% | -18.0% | |
| – | -137.8% | – | – | |
| – | -65.3% | +36.5% | +18.1% | |
| – | -65.3% | +958.6% | – | |
| – | -34.9% | – | -595.1% | |
| – | – | +420.5% | +915.2% | |
| – | -56.7% | -837.6% | – | |
| – | -95.4% | +63.1% | -1,224.2% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.